Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants
SARS-CoV-2 바이러스 변이체에 대한 백신 유도 전신 및 점막 T 세포 면역
Article
Published on
Journal: Proceedings of the National Academy of Sciences of [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료제,
Journal: Proceedings of the National Academy of Sciences of [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료제,
[키워드] absence
antibodies
B1.351
CD4
CD4 T cell
CD4 T cells
CD8 T cell
CD8 T cells
CLARITY
conserved
COVID-19 vaccine
Critical
detectable
effective
Effectiveness
elicit
epitope
Epitopes
evade
homologous
Hospitalization
Immunity
immunization
implication
Infection
knowledge
lack
lung immunopathology
Lung pathology
memory
memory T cell
memory T cells
mucosal
neutralized
Neutralizing antibodies
presence of antibody
presence or absence
PROTECT
Protective
protective vaccines
provided
SARS-CoV-2
SARS-CoV-2 vaccines
SARS-CoV-2 variant
SARS-CoV-2 variants
SARS-CoV-2 viral
T cell
T cell responses
T cells
Vaccine
variant
Viral
viral control
virus
virus-neutralizing antibodies
[DOI] 10.1073/pnas.2118312119 PMC 바로가기 [Article Type] Article
[DOI] 10.1073/pnas.2118312119 PMC 바로가기 [Article Type] Article